Roger Jeffs sold $1.7M of Axsome Therapeutics (AXSM)

Executed Sep 2 2025, disclosed Sep 2 2025, the same day.

Value, as filed

$1.7M

13,464 sh × $123.68

Executed

Sep 2 2025

the trade date, as filed

Disclosed

Sep 2 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

RJ Roger Jeffs Director profile →

Roger Jeffs (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Liquidia Corporation (LQDA). The largest single filing was $4.6M of LQDA (75,000 sh across 3 lots, as filed), executed May 21.

The name

AXSM

Axsome Therapeutics, Inc. AXSM · Healthcare · 34 filings in 24 months ticker →

Healthcare · Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Roger Jeffs in AXSM

AXSMSALE Axsome Therapeutics, Inc. $7.3M
60,000 sh across 3 lots
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET AXSMSALE Axsome Therapeutics, Inc. $4.4M
36,694 sh across 2 lots
Exec Aug 22 2025
Filed Aug 26 2025 · 5:30 PM ET